查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1654422

肢端肥大症治療市場規模、佔有率、趨勢分析報告：按藥物類別、分銷管道、地區和細分市場進行預測，2025-2030 年

Acromegaly Treatment Market Size, Share & Trends Analysis Report By Drug Class (Somatostatin Analogs, GHRA, Dopamine Agonists), By Distribution Channel (Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

肢端肥大症治療市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球肢端肥大症治療市場規模預計到2030年將達到23.7億美元，2025-2030年期間的複合年成長率為6.4%。肢端肥大症盛行率的不斷上升預計會推動疾病的成長。例如，內分泌學會的一份報告發現，2015 年疾病盛行率比 2014 年增加了四倍。此外，各製藥公司正在加大對臨床試驗的投資以開發新的分子，這也推動了市場的成長。

此外，強勁的藥物管道預計將在未來幾年創造成長機會。例如，Chiasma Inc.的Mycapssa於2016年在歐洲獲得核准。 2018年，Antisense Therapeutics在美國推出了新配方ALT1103。 Ionis Pharmaceuticals Inc. 的生長激素受體拮抗劑 ISIS 766720 目前正處於 II 期臨床試驗階段，預計將於 2019 年 12 月完成。

強勁的生長抑制素類似物管道預計將在不久的將來推動肢端肥大症治療市場的成長。例如，2018年北美進行了大約30項臨床試驗，其中許多正在等待美國食品藥物管理局（FDA）的核准。

肢端肥大症治療市場報告重點

  • 按藥物類別分類，生長抑制素類似物 (SSA) 將在 2024 年佔據最大的市場佔有率，為 65.0%。
  • 按分銷管道分類，醫院藥房部門在 2024 年佔據最大佔有率，為 49.8%。
  • 由於北美地區擁有先進的醫療保健基礎設施、較高的認知度以及能夠獲得最先進治療的機會，預計 2024 年北美地區的收入佔有率將達到 38.7%，位居第一。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 肢端肥大症治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

4. 肢端肥大症治療市場：藥物類別業務分析

  • 2024 年及 2030 年藥物類別市場佔有率
  • 藥品類別細分儀表板
  • 2018 年至 2030 年按藥物類別分類的市場規模、預測和趨勢分析
  • 生長抑制素類似物 (SSA)
  • 生長激素受體拮抗劑（GHRA）
  • 促效劑
  • 其他

第5章 肢端肥大症治療市場：通路業務分析

  • 分銷通路市場佔有率，2024 年和 2030 年
  • 分銷通路細分儀表板
  • 2018 年至 2030 年按分銷管道分類的市場規模、預測和趨勢分析
  • 醫院藥房
  • 零售藥局
  • 其他

第6章 肢端肥大症治療市場：按地區分類的估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Novartis AG
    • Ipsen Pharma
    • Sun Pharmaceutical Industries Ltd
    • Chiasma, Inc.
    • Peptron, Inc.
    • WOCKHARDT
    • Dauntless Pharmaceuticals
    • Pfizer Inc.
    • Ionis Pharmaceuticals, Inc.
Product Code: GVR-3-68038-053-8

Acromegaly Treatment Market Growth & Trends:

The global acromegaly treatment market size is estimated to reach USD 2.37 billion by 2030, registering a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of the acromegaly disease is expected to drive the growth. For instance, the disease prevalence increased fourfold in 2015 from its previous year 2014, according to a report by the Endocrine Society. Moreover, growing investment in clinical trials by various pharmaceutical companies to develop new molecules is another factor propelling the market growth.

Furthermore, strong pipeline of drugs is anticipated to create growth opportunities in the forthcoming years. For instance, Mycapssa by Chiasma Inc. received approval in Europe in 2016. In 2018, Antisense Therapeutics launched their new formulation ALT1103 in U.S. ISIS 766720 by Ionis Pharmaceuticals Inc., a growth hormone receptor antagonist is currently under phase II clinical trial and is expected to be finished by December 2019.

The strong pipeline of drugs for somatostatin analogs is expected to propel growth of the acromegaly treatment market in near future. For instance, in 2018 around 30 clinical trials were being conducted in North America and many are waiting for the U.S. Food and Drug Administration (FDA) approval.

Acromegaly Treatment Market Report Highlights:

  • By drug class, the somatostatin analogues (SSAs) segment captured the largest market share of 65.0% in 2024, owing to their effectiveness in controlling growth hormone levels and managing symptoms.
  • On the besis of distribution channel, the hospital pharmacies segment garnered the largest share of 49.8% in 2024, attributed to their critical role in providing immediate and specialized care.
  • North America recorded the largest revenue share of 38.7% in 2024, due to the region's advanced healthcare infrastructure, high awareness levels, and access to cutting-edge treatments.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Acromegaly Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Acromegaly Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2030
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, By Drug Class, 2018 to 2030 (USD Million)
  • 4.4. Somatostatin Analogues (SSAs)
    • 4.4.1. Somatostatin Analogues (SSAs) Market, 2018 - 2030 (USD Million)
  • 4.5. Growth Hormone Receptor Antagonists (GHRAs)
    • 4.5.1. Growth Hormone Receptor Antagonists (GHRAs) Market, 2018 - 2030 (USD Million)
  • 4.6. Dopamine Agonists
    • 4.6.1. Dopamine Agonists Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Acromegaly Treatment Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Acromegaly Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamic
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamic
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamic
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamic
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamic
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamic
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamic
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamic
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamic
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamic
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Norway Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamic
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamic
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamic
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamic
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamic
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamic
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamic
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamic
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamic
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamic
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamic
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamic
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamic
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Acromegaly Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Novartis AG
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Ipsen Pharma
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Sun Pharmaceutical Industries Ltd
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Chiasma, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Peptron, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. WOCKHARDT
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Dauntless Pharmaceuticals
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Pfizer Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Ionis Pharmaceuticals, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Acromegaly Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 5. Global Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6. North America Acromegaly Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8. North America Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10. U.S. Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11. Canada Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12. Canada Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 14. Mexico Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15. Europe Acromegaly Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17. Europe Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18. UK Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 19. UK Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20. Germany Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21. Germany Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22. France Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 23. France Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24. Italy Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25. Italy Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26. Spain Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 27. Spain Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28. Denmark Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 29. Denmark Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30. Norway Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 31. Norway Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32. Sweden Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33. Sweden Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Acromegaly Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37. Japan Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 38. Japan Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39. China Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 40. China Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41. India Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 42. India Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43. South Korea Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 44. South Korea Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45. Australia Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 46. Australia Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47. Thailand Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 48. Thailand Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 49. Latin America Acromegaly Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 51. Latin America Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52. Brazil Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 53. Brazil Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54. Argentina Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 55. Argentina Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Acromegaly Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59. South Africa Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60. South Africa Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63. UAE Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 64. UAE Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Acromegaly Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Acromegaly Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Acromegaly Treatment Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Drug Class and Distribution Channel Outlook (USD Million)
  • Fig. 10 Competitive Landscape
  • Fig. 11 Acromegaly Treatment Market Dynamics
  • Fig. 12 Acromegaly Treatment Market: Porter's Five Forces analysis
  • Fig. 13 Acromegaly Treatment Market: PESTLE Analysis
  • Fig. 14 Acromegaly Treatment Market: Drug Class Segment Dashboard
  • Fig. 15 Acromegaly Treatment Market: Drug Class Market Share Analysis, 2024 & 2030
  • Fig. 16 Somatostatin Analogues (SSAs) Market, 2018 - 2030 (USD Million)
  • Fig. 17 Growth Hormone Receptor Antagonists (GHRAs) Market, 2018 - 2030 (USD Million)
  • Fig. 18 Dopamine Agonists Market, 2018 - 2030 (USD Million)
  • Fig. 19 Others Market, 2018 - 2030 (USD Million)
  • Fig. 20 Acromegaly Treatment Market: Distribution Channel Segment Dashboard
  • Fig. 21 Acromegaly Treatment Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 22 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 23 Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 24 Others Market, 2018 - 2030 (USD Million)
  • Fig. 25 Acromegaly Treatment Market Revenue, By Region
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 Regional Marketplace: Key Takeaways
  • Fig. 28 North America Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Country Dynamics
  • Fig. 30 U.S. Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada Country Dynamics
  • Fig. 32 Canada Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Country Dynamics
  • Fig. 34 Mexico Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 36 UK Country Dynamics
  • Fig. 37 UK Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Country Dynamics
  • Fig. 39 Germany Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 40 France Country Dynamics
  • Fig. 41 France Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy Country Dynamics
  • Fig. 43 Italy Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Country Dynamics
  • Fig. 45 Spain Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Country Dynamics
  • Fig. 47 Denmark Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Country Dynamics
  • Fig. 49 Norway Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Country Dynamics
  • Fig. 51 Sweden Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Country Dynamics
  • Fig. 54 Japan Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 55 China Country Dynamics
  • Fig. 56 China Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 57 India Country Dynamics
  • Fig. 58 India Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea Country Dynamics
  • Fig. 60 South Korea Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia Country Dynamics
  • Fig. 62 Australia Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Country Dynamics
  • Fig. 64 Thailand Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Country Dynamics
  • Fig. 67 Brazil Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Country Dynamics
  • Fig. 69 Argentina Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 70 MEA Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa Country Dynamics
  • Fig. 72 South Africa Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia Country Dynamics
  • Fig. 74 Saudi Arabia Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE Country Dynamics
  • Fig. 76 UAE Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait Key Country Dynamics
  • Fig. 78 Kuwait Acromegaly Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 79 Company Categorization
  • Fig. 80 Company Market Position Analysis
  • Fig. 81 Strategic Framework